Biography
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artifical intelligence to increase the breadth of populations that can be reached. He developed and runs a digital care delivery program at SHC, providing virtual visits for patients and remote consultations for referring clinicians. He conducts research on and engages in collaborations around interventions that layer advances in machine learning on digital health capabilities to enhance access, quality and value of dermatologic care and is a founder and leader of the Stanford Translational AI in Dermatology (TRAIND) group. He chairs the American Academy of Dermatology's Committee on Augmented Intelligence.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss through various clinical trials and translational research efforts. He sits on the clinical research advisory board of the National Alopecia Areata Foundation and is a founder and co-director of the Skin Innovation and Interventional Research Group (SIIRG) which conducts clinical and translational research on skin disease.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Dermatology Residency Training Program where he served as chief resident.
Professional Summary
Education & Certifications
- Board Certification: American Board of Dermatology, Dermatology (2012)
- Chief Resident, Harvard Combined Dermatology Residency Training Program (2012)
- Residency: Massachusetts General Hospital (2012) MA
- BA, Harvard University, Magna Cum Laude (2002)
- MD, MBA, Tufts University School of Medicine, Alpha Omega Alpha (2008)
Memberships
- Chair, American Academy of Dermatology Committee on Augmented Intelligence (2019 - Present)
- Research Advisory Council, National Alopecia Areata Foundation (2016 - Present)
Administrative Appointments
- Associate Chief Quality Officer, Stanford Health Care (2021 - Present)
- Co-Chair, Clinic Advisory Council, Stanford Health Care (2018 - Present)
- Director of Network Development and Digital Health, Stanford Department of Dermatology (2012 - Present)
- Director of Value Based Care, Stanford Department of Dermatology (2020 - Present)
- Medical Director and Chief, Medical Dermatology, Stanford Health Care (2012 - Present)
- Medical Director, Service Excellence, Stanford Health Care (2018 - Present)
- Member, Access Management Guidance Team, Stanford Health Care (2018 - Present)
- Member, Ambulatory Value Optimization Committee, Stanford Health Care (2018 - Present)
- Member, Clinic Advisory Council, Stanford Hospital and Clinics (2015 - Present)
- Physician Dyadic partner to Chief Experience Officer, Stanford Health Care (2021 - Present)
- Physician Lead and Co-Chair, Clinic Performance Team 4, Stanford Hospital and Clinics (2015 - 2018)
- Physician Leader, Safety, Quality and Performance Improvement, Stanford Department of Dermatology (2017 - Present)
Publications
-
Prospective assessment of computer-aided detection in interpretation of screening mammography
Ko, J. M., Nicholas, M. J., Mendel, J. B., & Slanetz, P. J. (2006). Prospective assessment of computer-aided detection in interpretation of screening mammography. AMERICAN JOURNAL OF ROENTGENOLOGY, 187(6), 1483–91. -
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Ko, J. M., Gottlieb, A. B., & Kerbleski, J. F. (2009). Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases. JOURNAL OF DERMATOLOGICAL TREATMENT, 20(2), 100–108. -
Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis
Ko, J. M., & QURESHI, A. W. (2010). Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 145(3), 393–406. -
A new era: melanoma genetics and therapeutics
Ko, J. M., & Fisher, D. E. (2011). A new era: melanoma genetics and therapeutics. JOURNAL OF PATHOLOGY, 223(2), 241–50. -
Pathways to Melanoma
Ko, J. M., Velez, N. F., & Tsao, H. (2010). Pathways to Melanoma. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 29(4), 210–17. -
A Randomized, Prospective Trial Evaluating Surgeon Preference in Selection of Absorbable Suture Material
Lu, L. K., Ko, J. M., Lee, J., Krum, D. M., Price, L. L., Finn, D., … Rogers, G. S. (2012). A Randomized, Prospective Trial Evaluating Surgeon Preference in Selection of Absorbable Suture Material. JOURNAL OF DRUGS IN DERMATOLOGY, 11(2), 196–201. -
Paying for Enhanced Service Comparing Patients' Experiences in a Concierge and General Medicine Practice
Ko, J. M., Rodriguez, H. P., Fairchild, D. G., Rodday, A. M. C., & Safran, D. G. (2009). Paying for Enhanced Service Comparing Patients' Experiences in a Concierge and General Medicine Practice. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2(2), 95–103. -
Randomized Controlled Trial of Cryotherapy With Liquid Nitrogen vs Topical Salicylic Acid vs Wait-and-See for Cutaneous Warts
Ko, J., & Bigby, M. (2012). Randomized Controlled Trial of Cryotherapy With Liquid Nitrogen vs Topical Salicylic Acid vs Wait-and-See for Cutaneous Warts. ARCHIVES OF DERMATOLOGY, 148(7), 840–842. -
DermLens: Device for mobile teledermatology
Lai, I., Ko, J., & Pathipati, A. (2015). DermLens: Device for mobile teledermatology. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(5), AB88–AB88. -
Validation of a Skin-Lesion Image-Matching Algorithm Based on Computer Vision Technology
Chen, R. H., Snorrason, M., Enger, S. M., Mostafa, E., Ko, J. M., Aoki, V., & Bowling, J. (2016). Validation of a Skin-Lesion Image-Matching Algorithm Based on Computer Vision Technology. TELEMEDICINE AND E-HEALTH, 22(1), 45–50. -
Implementation and evaluation of Stanford Health Care direct-care teledermatology program.
Pathipati, A. S., & Ko, J. M. (2016). Implementation and evaluation of Stanford Health Care direct-care teledermatology program. SAGE Open Medicine, 4, 2050312116659089-? -
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.
Kennedy Crispin, M., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., … King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight, 1(15). -
Dermatologist-level classification of skin cancer with deep neural networks.
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–18. -
A case and review of congenital leukonychia.
Pathipati, A. S., Ko, J. M., & Yost, J. M. (2016). A case and review of congenital leukonychia. Dermatology Online Journal, 22(10). -
Crowdsourcing dermatology: DataDerm, big data analytics, and machine learning technology.
Park, A. J., Ko, J. M., & Swerlick, R. A. (2017). Crowdsourcing dermatology: DataDerm, big data analytics, and machine learning technology. Journal of the American Academy of Dermatology. -
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Crispin, M. K., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., … King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI INSIGHT, 1(15). -
Challenges and recommendations for epigenomics in precision health
Carter, A. C., Chang, H. Y., Church, G., Dombkowski, A., Ecker, J. R., Gil, E., … Wong, W. (2017). Challenges and recommendations for epigenomics in precision health. NATURE BIOTECHNOLOGY, 35(12), 1128–32. -
The importance of eyebrows in the treatment of alopecia areata: An online questionnaire
Liu, L., King, B., & Ko, J. (2018). The importance of eyebrows in the treatment of alopecia areata: An online questionnaire. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
Automated Classification of Skin Lesions: From Pixels to Practice.
Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J. (2018). Automated Classification of Skin Lesions: From Pixels to Practice. The Journal of Investigative Dermatology, 138(10), 2108–10. -
Implementation and evaluation of Stanford Health Care store-and-forward teledermatology consultation workflow built within an existing electronic health record system.
Kim, G. E., Afanasiev, O. K., O'Dell, C., Sharp, C., & Ko, J. M. (2018). Implementation and evaluation of Stanford Health Care store-and-forward teledermatology consultation workflow built within an existing electronic health record system. Journal of Telemedicine and Telecare, 1357633X18799805. -
Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata.
Gordon, S. C., Abudu, M., Zancanaro, P., Ko, J. M., & Rosmarin, D. (2018). Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata. Journal of the European Academy of Dermatology and Venereology : JEADV. -
Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab.
Zhu, G. A., Chen, J. K., Chiou, A., Ko, J., & Honari, G. (2019). Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab. JAAD Case Reports, 5(4), 336–38. -
Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab.
Zhu, G. A., Chen, J. K., Chiou, A., Ko, J., & Honari, G. (2019). Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab. JAMA Dermatology. -
Artificial intelligence and dermatology: opportunities, challenges, and future directions.
Schlessinger, D. I., Chhor, G., Gevaert, O., Swetter, S. M., Ko, J., & Novoa, R. A. (2019). Artificial intelligence and dermatology: opportunities, challenges, and future directions. Seminars in Cutaneous Medicine and Surgery, 38(1), E31–37. -
New regional dermatoses during dupilumab therapy for atopic dermatitis
Zhu, G. A., Chen, J. K., Chiou, A., Ko, J. M., & Honari, G. (2019). New regional dermatoses during dupilumab therapy for atopic dermatitis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S92. -
Commentary: Position Statement on Augmented Intelligence (AuI).
Kovarik, C., Lee, I., & Ko, J. (2019). Commentary: Position Statement on Augmented Intelligence (AuI). Journal of the American Academy of Dermatology. -
Marking the Path Toward Artificial Intelligence-Based Image Classification in Dermatology.
Novoa, R. A., Gevaert, O., & Ko, J. M. (2019). Marking the Path Toward Artificial Intelligence-Based Image Classification in Dermatology. JAMA Dermatology. -
Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab
Zhu, G. A., Chen, J. K., Chiou, A., Ko, J., & Honari, G. (2019). Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab. JAMA DERMATOLOGY, 155(7), 850–52. -
The Alopecia Areata Investigator's Global Assessment (AA-IGA) scale: A measure for evaluating clinically meaningful success in clinical trials
Wyrwich, K. W., Kitchen, H., Knight, S., Aldhouse, N. V. J., Macey, J., Nunes, F. P., … King, B. A. (2019). The Alopecia Areata Investigator's Global Assessment (AA-IGA) scale: A measure for evaluating clinically meaningful success in clinical trials. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 81(4), AB283. -
Artificial intelligence and dermatology: opportunities, challenges, and future directions
Schlessinger, D. I., Chhor, G., Gevaert, O., Swetter, S. M., Ko, J., & Novoa, R. A. (2019). Artificial intelligence and dermatology: opportunities, challenges, and future directions. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 38(1), E31–E37. -
Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution.
Zhu, G. A., Kang, K. J., Chen, J. K., Novoa, R. A., Brown, R. A., Chiou, A. S., … Honari, G. (2019). Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution. Journal of the European Academy of Dermatology and Venereology : JEADV. -
Dupilumab Treatment of Nummular Dermatitis: A Retrospective Cohort Study.
Choi, S., Zhu, G. A., Lewis, M. A., Honari, G., Chiou, A. S., Ko, J., & Chen, J. K. (2020). Dupilumab Treatment of Nummular Dermatitis: A Retrospective Cohort Study. Journal of the American Academy of Dermatology. -
Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study.
Nelson, C. A., Perez-Chada, L. M., Creadore, A., Li, S. J., Lo, K., Manjaly, P., … Mostaghimi, A. (2020). Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study. JAMA Dermatology. -
Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report.
Zhu, G. A., Honari, G., Ko, J. M., Chiou, A. S., & Chen, J. K. (2020). Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report. JAAD Case Reports, 6(4), 296–98. -
Innovation interest within dermatology: a needs assessment for novel thought processes.
Lee, K. C., Lee, I., Okhovat, J.-P., Ko, J., Powers, J. G., Ellis, D. L., … Garibyan, L. (2020). Innovation interest within dermatology: a needs assessment for novel thought processes. Archives of Dermatological Research. -
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
Wyrwich, K. W., Kitchen, H., Knight, S., Aldhouse, N. V., Macey, J., Nunes, F. P., … King, B. A. (2020). Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata. American Journal of Clinical Dermatology. -
Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.
Wyrwich, K. W., Kitchen, H., Knight, S., Aldhouse, N. V., Macey, J., Nunes, F. P., … King, B. A. (2020). Development of the Scalp Hair Assessment PRO™ measure for alopecia areata. The British Journal of Dermatology. -
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
Wyrwich, K. W., Kitchen, H., Knight, S., Aldhouse, N. V., Macey, J., Nunes, F. P., … King, B. A. (2020). The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials. The British Journal of Dermatology. -
Pernio-like eruption associated with COVID-19 in skin of color.
Daneshjou, R., Rana, J., Dickman, M., Yost, J. M., Chiou, A., & Ko, J. (2020). Pernio-like eruption associated with COVID-19 in skin of color. JAAD Case Reports, 6(9), 892–97. -
"'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata.
Aldhouse, N. V., Kitchen, H., Knight, S., Macey, J., Nunes, F. P., Dutronc, Y., … Wyrwich, K. W. (2020). "'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata. Journal of Patient-Reported Outcomes, 4(1), 76. -
Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata.
Tkachenko, E., Huang, K. P., Ko, J. M., Liu, K. J., Scott, D. A., Senna, M. M., … Mostaghimi, A. (2020). Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata. The Journal of Investigative Dermatology. Symposium Proceedings, 20(1), S41–S44. -
The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
Wyrwich, K. W., Kitchen, H., Knight, S., Aldhouse, N. V., Macey, J., Nunes, F., … King, B. A. (2020). The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms. The Journal of Investigative Dermatology. Symposium Proceedings, 20(1), S71–S77. -
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study.
Mesinkovska, N., King, B., Mirmirani, P., Ko, J., & Cassella, J. (2020). Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study. The Journal of Investigative Dermatology. Symposium Proceedings, 20(1), S62–S68. -
Eyebrows Are Important in the Treatment of Alopecia Areata.
Liu, L. Y., King, B. A., & Ko, J. M. (2020). Eyebrows Are Important in the Treatment of Alopecia Areata. The Journal of Investigative Dermatology. Symposium Proceedings, 20(1), S37–S40. -
Clinical translation of choline and geranic acid deep eutectic solvent
Ko, J., Mandal, A., Dhawan, S., Shevachman, M., Mitragotri, S., & Joshi, N. (2020). Clinical translation of choline and geranic acid deep eutectic solvent. BIOENGINEERING & TRANSLATIONAL MEDICINE. -
Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib.
Nguyen, J., Chen, J. K., Honari, G., Pol-Rodriguez, M., Ko, J. M., & Chiou, A. S. (2021). Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib. JAAD Case Reports, 7, 65–67. -
TrueImage: A Machine Learning Algorithm to Improve the Quality of Telehealth Photos.
Vodrahalli, K., Daneshjou, R., Novoa, R. A., Chiou, A., Ko, J. M., & Zou, J. (2021). TrueImage: A Machine Learning Algorithm to Improve the Quality of Telehealth Photos. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 26, 220–31. -
Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata.
Manjaly, P., Li, S. J., Tkachenko, E., Ko, J. M., Liu, K. J., Scott, D. A., … Huang, K. P. (2021). Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata. Journal of the American Academy of Dermatology. -
Raising the bar for Randomized Trials involving Artificial Intelligence: The SPIRIT-AI and CONSORT-AI Guidelines.
Taylor, M., Liu, X., Denniston, A., Esteva, A., Ko, J., Daneshjou, R., & Chan, A.-W. (2021). Raising the bar for Randomized Trials involving Artificial Intelligence: The SPIRIT-AI and CONSORT-AI Guidelines. The Journal of Investigative Dermatology. -
Management of a Child vs an Adult Presenting With Acral Lesions During the COVID-19 Pandemic: A Practical Review
Clawson, R. C., Tabata, M. M., & Ko, J. M. (2021). Management of a Child vs an Adult Presenting With Acral Lesions During the COVID-19 Pandemic: A Practical Review. CUTIS, 107(3), 139–42. -
Automated Classification of Skin Lesions: From Pixels to Practice
Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J. (2018). Automated Classification of Skin Lesions: From Pixels to Practice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(10), 2108–2110. -
Clinical translation of choline and geranic acid deep eutectic solvent.
Ko, J., Mandal, A., Dhawan, S., Shevachman, M., Mitragotri, S., & Joshi, N. (2021). Clinical translation of choline and geranic acid deep eutectic solvent. Bioengineering & Translational Medicine, 6(2), e10191. -
Dermatologists' Perspectives on Artificial Intelligence and Augmented Intelligence-A Cross-sectional Survey.
Nelson, C. A., Pachauri, S., Balk, R., Miller, J., Theunis, R., Ko, J. M., & Kovarik, C. L. (2021). Dermatologists' Perspectives on Artificial Intelligence and Augmented Intelligence-A Cross-sectional Survey. JAMA Dermatology. -
Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care.
Schwartz, B. L., Honari, G., Chiou, A. S., Ko, J., Sarin, K. Y., & Chen, J. K. (2021). Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care. Journal of the American Academy of Dermatology. -
Effect of dupilumab on the host-microbe interface in atopic dermatitis
Beck, L. A., Boguniewicz, M., Hatta, T., Fuxench, Z. C., Simpson, E., De Benedetto, A., … Leung, D. (2021). Effect of dupilumab on the host-microbe interface in atopic dermatitis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 141(5), S116. -
Dermatology consent form readability: A barrier to comprehension and inclusivity
Faletsky, A., Han, J. J., Li, S. J., Lee, K., Soliman, Y., Stephens, M., … Mostaghimi, A. (2021). Dermatology consent form readability: A barrier to comprehension and inclusivity. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 141(5), S69. -
Implementation of Stanford Health Care direct-care teledermatology program
Pathipati, A., & Ko, J. (2016). Implementation of Stanford Health Care direct-care teledermatology program. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(5), AB106. -
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.
King, B., Ko, J., Forman, S., Ohyama, M., Mesinkovska, N., Yu, G., … Dutronc, Y. (2021). Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study. Journal of the American Academy of Dermatology. -
Association of Resilience and Perceived Stress in Patients with Alopecia Areata: A Cross Sectional Study.
Han, J. J., Li, S. J., Joyce, C. J., Burns, L. J., Yekrang, K., Senna, M. M., … Mostaghimi, A. (2021). Association of Resilience and Perceived Stress in Patients with Alopecia Areata: A Cross Sectional Study. Journal of the American Academy of Dermatology. -
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims.
Senna, M., Ko, J., Tosti, A., Edson-Heredia, E., Fenske, D. C., Ellinwood, A. K., … King, B. (2021). Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims. Advances in Therapy. -
Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial
Ko, J., Roberts, J., Hordinsky, M., Taylor, S., Mostaghimi, A., Chiasserini, C., … Dutronc, Y. (2021). Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
Foundational Considerations for Artificial Intelligence Utilizing Ophthalmic Images.
Abramoff, M. D., Cunningham, B., Patel, B., Eydelman, M. B., Leng, T., Sakamoto, T., … Char, D. (2021). Foundational Considerations for Artificial Intelligence Utilizing Ophthalmic Images. Ophthalmology. -
Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
King, B., Kwon, O., Mesinkovska, N., Ko, J., Dutronc, Y., Wu, W., … Hordinsky, M. (2021). Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1). JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Development of the Alopecia Areata Scale for Clinical Use: Results of an Academic-Industry Collaborative Effort.
King, B. A., Mesinkovska, N. A., Craiglow, B., Kindred, C., Ko, J., McMichael, A., … Senna, M. M. (2021). Development of the Alopecia Areata Scale for Clinical Use: Results of an Academic-Industry Collaborative Effort. Journal of the American Academy of Dermatology. -
Dermatology consent form readability as a barrier to comprehension and inclusivity: a cross-sectional study.
Faletsky, A., Han, J. J., Soliman, Y., Stephens, M., Li, S., Lee, K. J., … Mostaghimi, A. (2021). Dermatology consent form readability as a barrier to comprehension and inclusivity: a cross-sectional study. Journal of the American Academy of Dermatology. -
It's all alopecia areata - it's time to abandon the terms alopecia totalis and alopecia universalis.
Peterson, D., Craiglow, B. G., Mesinkovska, N. A., Ko, J., Senna, M. M., & King, B. (2021). It's all alopecia areata - it's time to abandon the terms alopecia totalis and alopecia universalis. Journal of the American Academy of Dermatology. -
TrueImage: A Machine Learning Algorithm to Improve the Quality of Telehealth Photos
Vodrahalli, K., Daneshjou, R., Novoa, R. A., Chiou, A., Ko, J. M., & Zou, J. (2021). TrueImage: A Machine Learning Algorithm to Improve the Quality of Telehealth Photos. PACIFIC SYMPOSIUM ON BICOMPUTING 2021. WORLD SCIENTIFIC PUBL CO PTE LTD. -
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King, B., Ohyama, M., Kwon, O., Zlotogorski, A., Ko, J., Mesinkovska, N. A., … Sinclair, R. (2022). Two Phase 3 Trials of Baricitinib for Alopecia Areata. The New England Journal of Medicine. -
Predictors of Quality of Life in Patients with Alopecia Areata.
Senna, M., Ko, J., Glashofer, M., Walker, C., Ball, S., Heredia, E. E.-, … Shapiro, J. (2022). Predictors of Quality of Life in Patients with Alopecia Areata. The Journal of Investigative Dermatology. -
Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.
King, B. A., Senna, M. M., Ohyama, M., Tosti, A., Sinclair, R. D., Ball, S., … Shapiro, J. (2022). Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework. Dermatology and Therapy. -
Effect of Dupilumab on the Host-Microbe Interface in Atopic Dermatitis
Beck, L., Boguniewicz, M., Hata, T., Fuxench, Z., Simpson, E., De Benedetto, A., … Leung, D. (2022). Effect of Dupilumab on the Host-Microbe Interface in Atopic Dermatitis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER. -
Partnering with a senior living community to optimize teledermatology via full body skin screening during the COVID-19 pandemic: a pilot program
Trinh, P., Yekrang, K., Phung, M., Pugliese, S., Chang, A. L. S., Bailey, E. E., … Sarin, K. Y. (2022). Partnering with a senior living community to optimize teledermatology via full body skin screening during the COVID-19 pandemic: a pilot program. Skin Health and Disease, 2(3). -
Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
Wyrwich, K. W., Kitchen, H., Knight, S., Aldhouse, N. V., Macey, J., Mesinkovska, N., … King, B. A. (2022). Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata. Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. -
Teledermatology to Facilitate Patient Care Transitions From Inpatient to Outpatient Dermatology: Mixed Methods Evaluation.
Kling, S. M., Saliba-Gustafsson, E. A., Winget, M., Aleshin, M. A., Garvert, D. W., Amano, A., … Ko, J. M. (2022). Teledermatology to Facilitate Patient Care Transitions From Inpatient to Outpatient Dermatology: Mixed Methods Evaluation. Journal of Medical Internet Research, 24(8), e38792. -
Disparities in dermatology AI performance on a diverse, curated clinical image set.
Daneshjou, R., Vodrahalli, K., Novoa, R. A., Jenkins, M., Liang, W., Rotemberg, V., … Chiou, A. S. (2022). Disparities in dermatology AI performance on a diverse, curated clinical image set. Science Advances, 8(32), eabq6147. -
Artificial Intelligence in the Detection of Skin Cancer.
Beltrami, E. J., Brown, A. C., Salmon, P. J., Leffell, D. J., Ko, J. M., & Grant-Kels, J. M. (2022). Artificial Intelligence in the Detection of Skin Cancer. Journal of the American Academy of Dermatology. -
A Cross-Sectional Analysis of The Environmental and Cost-Saving Benefits of Digital Dermatologic Care.
Gomez, J., Rizk, N., Linos, E., Ko, J. M., & Bailey, E. E. (2022). A Cross-Sectional Analysis of The Environmental and Cost-Saving Benefits of Digital Dermatologic Care. Journal of the American Academy of Dermatology. -
Impact of the COVID-19 pandemic on dermatology visits among older adults and racial and ethnic minorities
Rizk, N., Mathur, M. B., Ko, J., Chiou, A., Hunt, I. de V., van Egmond, S., & Linos, E. (2022). Impact of the COVID-19 pandemic on dermatology visits among older adults and racial and ethnic minorities. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Development of a digital tool for home-based monitoring of skin disease for older adults
van Egmond, S., Cai, Z., Nava, V., Rapaport, B., Ko, J., Chiou, A., … Linos, E. (2022). Development of a digital tool for home-based monitoring of skin disease for older adults. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Rapid reduction in S. aureus & cytotoxins in dupilumab treated atopic dermatitis subjects
Beck, L. A., Boguniewicz, M., Hata, T., Fuxench, Z., Simpson, E., De Benedetto, A., … Leung, D. Y. (2022). Rapid reduction in S. aureus & cytotoxins in dupilumab treated atopic dermatitis subjects. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
A Multicenter Descriptive Analysis of 270 Men with Frontal Fibrosing Alopecia and Lichen Planopilaris in the United States.
Pathoulas, J. T., Flanagan, K. E., Walker, C. J., Collins, M. S., Ali, S., Pupo Wiss, I. M., … Senna, M. M. (2022). A Multicenter Descriptive Analysis of 270 Men with Frontal Fibrosing Alopecia and Lichen Planopilaris in the United States. Journal of the American Academy of Dermatology. -
Optimizing Virtual Visits and Reducing Inbox Messages Using a Pre-Visit Questionnaire: A Quality Improvement Project.
Gomez, J., Mazzoleni, M., Calugar, A., Pol-Rodriguez, M., Ko, J. M., & Bailey, E. E. (2023). Optimizing Virtual Visits and Reducing Inbox Messages Using a Pre-Visit Questionnaire: A Quality Improvement Project. Journal of the American Academy of Dermatology. -
Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo Quality.
Vodrahalli, K., Ko, J., Chiou, A. S., Novoa, R., Abid, A., Phung, M., … Daneshjou, R. (2023). Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo Quality. JAMA Dermatology. -
Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment.
Simpson, E. L., Schlievert, P. M., Yoshida, T., Lussier, S., Boguniewicz, M., Hata, T., … Beck, L. A. (2023). Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment. The Journal of Allergy and Clinical Immunology. -
Best Practices for Clinical Skin Image Acquisition in Translational Artificial Intelligence Research.
Phung, M., Muralidharan, V., Rotemberg, V., Novoa, R. A., Chiou, A. S., Sadée, C. Y., … Daneshjou, R. (2023). Best Practices for Clinical Skin Image Acquisition in Translational Artificial Intelligence Research. The Journal of Investigative Dermatology, 143(7), 1127–1132. -
Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory programs and critical cell types for hair and skin diseases.
Ober-Reynolds, B., Wang, C., Ko, J. M., Rios, E. J., Aasi, S. Z., Davis, M. M., … Greenleaf, W. J. (2023). Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory programs and critical cell types for hair and skin diseases. Nature Genetics. -
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials.
Ko, J. M., Mayo, T. T., Bergfeld, W. F., Dutronc, Y., Yu, G., Ball, S. G., … Craiglow, B. G. (2023). Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials. JAMA Dermatology. -
Association between yearlong air pollution and moderate-severe atopic dermatitis: A United States cross-sectional claims analysis.
Trinh, P., Allerup, J. A., Li, S., Ko, J., Chen, J., Linos, E., & Chiou, A. S. (2023). Association between yearlong air pollution and moderate-severe atopic dermatitis: A United States cross-sectional claims analysis. JAAD International, 13, 4–6. -
Evolution of a Project to Improve Inpatient-to-Outpatient Dermatology Care Transitions: Mixed Methods Evaluation.
Kling, S. M., Aleshin, M. A., Saliba-Gustafsson, E. A., Garvert, D. W., Brown-Johnson, C. G., Amano, A., … Winget, M. (2023). Evolution of a Project to Improve Inpatient-to-Outpatient Dermatology Care Transitions: Mixed Methods Evaluation. JMIR Dermatology, 6, e43389. -
Rapid reduction in S. aureus in atopic dermatitis subjects following dupilumab treatment
Simpson, E., Schlievert, P., Yoshida, T., Lussier, S., Boguniewicz, M., Hata, T., … Beck, L. (2023). Rapid reduction in S. aureus in atopic dermatitis subjects following dupilumab treatment. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study.
Thaci, D., Tziotzios, C., Ito, T., Ko, J., Karadag, A. S., Fang, H., … Law, E. (2023). Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. Dermatology and Therapy. -
Development of a digital tool for home-based monitoring of skin disease for older adults.
van Egmond, S., Cai, Z. R., Nava, V., Joy de Vere Hunt, I., Rapaport, B. R., Ko, J., … Linos, E. (2023). Development of a digital tool for home-based monitoring of skin disease for older adults. Skin Health and Disease, 3(5), e235. -
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Thaci, D., Tziotzios, C., Ito, T., Ko, J., Karadag, A. S., Fang, H., … Law, E. (2023). Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. DERMATOLOGY AND THERAPY. -
Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
King, B., Ko, J., Piraccini, B. M., Shimomura, Y., Dutron, Y., Wu, W.-S., … Sinclair, R. (2023). Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
Shapiro, J., Ko, J., Egeberg, A., Somani, N., Jedynak, J., Torisu-Itakura, H., … Craiglow, B. (2023). Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib
King, B., Ko, J., Senna, M., Tosti, A., Ohyama, M., Dutronc, Y., … Wu, W.-S. (2023). Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance.
Thomas, L., Hyde, C., Mullarkey, D., Greenhalgh, J., Kalsi, D., & Ko, J. (2023). Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance. Frontiers in Medicine, 10, 1264846. -
Best Practices for Research in Virtual and Augmented Reality in Dermatology.
Muralidharan, V., Tran, M. M., Barrios, L., Beams, B., Ko, J. M., Siegel, D. H., & Bailenson, J. (2024). Best Practices for Research in Virtual and Augmented Reality in Dermatology. The Journal of Investigative Dermatology, 144(1), 17–23. -
Dermatologists' perspectives and usage of large language models in practice- an exploratory survey.
Gui, H., Rezaei, S. J., Schlessinger, D., Weed, J., Lester, J., Wongvibulsin, S., … Daneshjou, R. (2024). Dermatologists' perspectives and usage of large language models in practice- an exploratory survey. The Journal of Investigative Dermatology. -
Telehealth Utilization and Associations in the United States During the Third Year of the COVID-19 Pandemic: Population-Based Survey Study in 2022.
Kim, J., Cai, Z. R., Chen, M. L., Onyeka, S., Ko, J. M., & Linos, E. (2024). Telehealth Utilization and Associations in the United States During the Third Year of the COVID-19 Pandemic: Population-Based Survey Study in 2022. JMIR Public Health and Surveillance, 10, e51279. -
Response: Commentary: Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance.
Thomas, L., Hyde, C., Mullarkey, D., Greenhagh, J., Kalsi, D., & Ko, J. (2024). Response: Commentary: Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance. Frontiers in Medicine, 11, 1388422. -
Electronic consultation in supportive oncodermatology: a single center retrospective cohort.
Betancourt, N. J., Johnson, A. N., Clawson, R. C., Ko, J. M., & Rana, J. K. (2024). Electronic consultation in supportive oncodermatology: a single center retrospective cohort. Dermatology Online Journal, 30(1). -
Editorial: Artificial intelligence in cutaneous lesions: where do we stand and what is next?
Giavina-Bianchi, M., & Ko, J. (2024). Editorial: Artificial intelligence in cutaneous lesions: where do we stand and what is next? Frontiers in Medicine, 11, 1420152. -
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: results from BRAVE-AA1 and BRAVE-AA2 studies.
Mostaghimi, A., Ko, J., Tosti, A., McMichael, A., Ohyama, M., Ito, T., … Wollenberg, A. (2024). Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: results from BRAVE-AA1 and BRAVE-AA2 studies. Journal of the American Academy of Dermatology. -
Multi-institutional retrospective review of acute generalized exanthematous pustulosis (AGEP) induced by hydroxychloroquine
Bang, A. S., Blank, N. R., Fox, L., Ko, J., Worswick, S., & Harp, J. (2024). Multi-institutional retrospective review of acute generalized exanthematous pustulosis (AGEP) induced by hydroxychloroquine. JEADV CLINICAL PRACTICE, 3(2), 641–646. -
Single-Lesion Skin Cancer Risk Stratification Triage Pathway.
Chen, Y., Gui, H., Yao, H., Adu-Brimpong, J., Javitz, S., Golovko, V., … Chiou, A. S. (2024). Single-Lesion Skin Cancer Risk Stratification Triage Pathway. JAMA Dermatology. -
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial.
King, B., Ko, J., Kwon, O., Vañó-Galván, S., Piraccini, B. M., Dutronc, Y., … Mesinkovska, N. A. (2024). Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial. JAMA Dermatology. -
Dermoscopic and clinical image dataset for AI research in dermatology
Gui, H., Chiou, A., Omiye, J., Cai, Z. R., Ko, J., Swetter, S., … Novoa, R. (2024). Dermoscopic and clinical image dataset for AI research in dermatology. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Cutaneous CERS1 expression is a biomarker of staphylococcus aureus abundance and atopic dermatitis severity
Kenney, H., Yoshida, T., Berdyshev, E., Calatroni, A., Gill, S., Simpson, E., … Beck, L. A. (2024). Cutaneous CERS1 expression is a biomarker of staphylococcus aureus abundance and atopic dermatitis severity. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Humans vs large language models: An assessment of evaluating online dermatological misinformation
Fanous, A. H., Le, M., Rezaei, S., Xu, S., Ko, J., Lipoff, J., & Daneshjou, R. (2024). Humans vs large language models: An assessment of evaluating online dermatological misinformation. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Cutaneous Ceramide Synthase 1 (CERS1) Gene Expression is a Biomarker of Staphylococcus aureus Abundance and Severity of Atopic Dermatitis
MarkKenney, H., Yoshida, T., Berdyshev, E., Calatroni, A., Gill, S., Simpson, E., … Beck, L. (2024). Cutaneous Ceramide Synthase 1 (CERS1) Gene Expression is a Biomarker of Staphylococcus aureus Abundance and Severity of Atopic Dermatitis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER. -
CERS1 is a Biomarker of Staphylococcus aureus Abundance and Atopic Dermatitis Severity.
Kenney, H. M., Yoshida, T., Berdyshev, E., Calatroni, A., Gill, S. R., Simpson, E. L., … Beck, L. A. (2024). CERS1 is a Biomarker of Staphylococcus aureus Abundance and Atopic Dermatitis Severity. The Journal of Allergy and Clinical Immunology.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis
- A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata
- Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
- A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
- Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
- A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
Practice Locations
General Dermatology Clinic at Hoover Pavilion Palo Alto, CA
Palo Alto, CAGeneral Dermatology Clinic at Hoover Pavilion
211 Quarry Road, 3rd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereGeneral Dermatology Clinic in Redwood City Redwood City, CA
Redwood City, CAGeneral Dermatology Clinic in Redwood City
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HerePsoriasis Clinic Redwood City, CA
Redwood City, CAPsoriasis Clinic
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereSkin Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CASkin Cancer Program in Palo Alto
900 Blake Wilbur Drive, 3rd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereHigh-Risk Skin Cancer Clinic Redwood City, CA
Redwood City, CAHigh-Risk Skin Cancer Clinic
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HerePigmented Lesion and Melanoma Clinic at Stanford Medicine Outpatient Center Redwood City, CA
Redwood City, CAPigmented Lesion and Melanoma Clinic at Stanford Medicine Outpatient Center
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(253 reviews)
View More
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records